Public Contracts Scotland · Contract

NP47825 Multiple Sclerosis Medicines

A public procurement published by Clyde Gateway Development Ltd via Public Contracts Scotland.

Public Contracts ScotlandContract
Award value
£51.5m
Tender value
8
Suppliers
9
Awards
2
Notices
Contract
Stage

Overview

Supply of multiple sclerosis medicines to NHS Scotland.

Key details

Source
Public Contracts Scotland
Lifecycle stage
Contract
Status
active
CPV classification
33600000
Currency
GBP
Total award value
Tender value
£51,517,832
First published
7 Jan 2025
Last updated
2 May 2025
View the original notice

Awards

9 awards recorded on this procurement.

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeNP47825 Multiple Sclerosis Medicines
  2. Award,contractNP47825 Multiple Sclerosis Medicines

All suppliers

Frameworks & programmes

More from Clyde Gateway Development Ltd

FAQs about this procurement

Who is the buyer for "NP47825 Multiple Sclerosis Medicines"?

NP47825 Multiple Sclerosis Medicines is a UK public-sector procurement published by Clyde Gateway Development Ltd via Public Contracts Scotland.

Has "NP47825 Multiple Sclerosis Medicines" been awarded?

Yes — 9 awards are recorded, with a reported total value of £51,517,832. The current lifecycle stage is "Contract".

Which suppliers are involved in "NP47825 Multiple Sclerosis Medicines"?

8 suppliers are linked: Saltire Roofing & Building Ltd, Frazer Nash Consultancy, George Leslie Ltd, GEESINKNORBA, Saint-Gobain, Grifols Uk Ltd, Smith Brothers Marine Ltd, Aebi Schmidt UK Ltd.

What is "NP47825 Multiple Sclerosis Medicines" worth?

The reported tender value is £51,517,832.

When was "NP47825 Multiple Sclerosis Medicines" published?

It was first published on 7 Jan 2025 and last updated on 2 May 2025, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable